Injective (INJ) is currently priced at $4.63, reflecting a 24-hour change of -2.20%. The daily trading range has been relatively tight, with a high of $4.73 and a low of $4.48, indicating some price consolidation within a narrow band.

Volume stands at approximately 50.51 million, representing 10.91% of the market cap, which suggests active trading but not excessive speculation. The short-term moving averages are predominantly positive, with the 8 SMA at $4.59 showing a slight upward momentum, while the 55 SMA at $4.68 indicates a potential resistance level.

The 1-hour RSI at 58 suggests that the asset is approaching overbought territory, while the 7-day RSI at 42 indicates bearish momentum and a potential for further downside in the near term. Price changes over 7, 14, and 30 days reveal a notable downtrend, with the 7-day drop of approximately -17.76% indicating a recent sell-off.

The all-time high for INJ was $52.62 reached on March 14, 2024, which emphasizes the considerable distance the current price is from its peak, indicating significant room for recovery or heightened volatility. Given the current price action, technical indicators, and recent trends, the market sentiment appears cautious.

Overall, the combination of current price action, RSI levels, and recent price trends suggest a bearish outlook in the short to medium term. Therefore, the recommendation for Injective (INJ) is a Sell rating, as the asset shows signs of continued weakness and potential further declines in price.